• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

菲律宾黏多糖贮积症II型——亨特综合征患者的临床、生化及分子特征

Clinical, biochemical and molecular characteristics of Filipino patients with mucopolysaccharidosis type II - Hunter syndrome.

作者信息

Chiong Mary Anne D, Canson Daffodil M, Abacan Mary Ann R, Baluyot Melissa Mae P, Cordero Cynthia P, Silao Catherine Lynn T

机构信息

Institute of Human Genetics, National Institutes of Health, University of the Philippines Manila, 625 Pedro Gil St., Ermita, Manila, 1000, Philippines.

Department of Pediatrics, University of the Philippines-Philippine General Hospital, Manila, Philippines.

出版信息

Orphanet J Rare Dis. 2017 Jan 11;12(1):7. doi: 10.1186/s13023-016-0558-0.

DOI:10.1186/s13023-016-0558-0
PMID:28077157
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5225557/
Abstract

BACKGROUND

Mucopolysaccharidosis type II, an X-linked recessive disorder is the most common lysosomal storage disease detected among Filipinos. This is a case series involving 23 male Filipino patients confirmed to have Hunter syndrome. The clinical and biochemical characteristics were obtained and mutation testing of the IDS gene was done on the probands and their female relatives.

RESULTS

The mean age of the patients was 11.28 (SD 4.10) years with an average symptom onset at 1.2 (SD 1.4) years. The mean age at biochemical diagnosis was 8 (SD 3.2) years. The early clinical characteristics were developmental delay, joint stiffness, coarse facies, recurrent respiratory tract infections, abdominal distention and hernia. Majority of the patients had joint contractures, severe intellectual disability, error of refraction, hearing loss and valvular regurgitation on subspecialists' evaluation. The mean GAG concentration was 506.5 mg (SD 191.3)/grams creatinine while the mean plasma iduronate-2-sulfatase activity was 0.86 (SD 0.79) nmol/mg plasma/4 h. Fourteen (14) mutations were found: 6 missense (42.9%), 4 nonsense (28.6%), 2 frameshift (14.3%), 1 exon skipping at the cDNA level (7.1%), and 1 gross insertion (7.1%). Six (6) novel mutations were observed (43%): p.C422F, p.P86Rfs44, p.Q121, p.L209Wfs*4, p.T409R, and c.1461_1462insN[710].

CONCLUSION

The age at diagnosis in this series was much delayed and majority of the patients presented with severe neurologic impairment. The results of the biochemical tests did not contribute to the phenotypic classification of patients. The effects of the mutations were consistent with the severe phenotype seen in the majority of the patients.

摘要

背景

II型粘多糖贮积症是一种X连锁隐性疾病,是菲律宾人中最常见的溶酶体贮积病。这是一个病例系列,涉及23名确诊患有亨特综合征的菲律宾男性患者。获取了临床和生化特征,并对先证者及其女性亲属进行了IDS基因的突变检测。

结果

患者的平均年龄为11.28(标准差4.10)岁,平均症状出现年龄为1.2(标准差1.4)岁。生化诊断的平均年龄为8(标准差3.2)岁。早期临床特征为发育迟缓、关节僵硬、面容粗糙、反复呼吸道感染、腹胀和疝气。在专科评估中,大多数患者有关节挛缩、严重智力残疾、屈光不正、听力丧失和瓣膜反流。平均糖胺聚糖浓度为506.5毫克(标准差191.3)/克肌酐,而平均血浆艾杜糖醛酸-2-硫酸酯酶活性为0.86(标准差0.79)纳摩尔/毫克血浆/4小时。发现了14种突变:6种错义突变(42.9%)、4种无义突变(28.6%)、2种移码突变(14.3%)、1种cDNA水平的外显子跳跃(7.1%)和1种大片段插入(7.1%)。观察到6种(6)新突变(43%):p.C422F、p.P86Rfs44、p.Q121、p.L209Wfs*4、p.T409R和c.1461_1462insN[710]。

结论

该系列中的诊断年龄延迟很多,大多数患者表现出严重的神经功能损害。生化检测结果对患者的表型分类没有帮助。突变的影响与大多数患者中观察到的严重表型一致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/025c/5225557/1d73b18c5ea9/13023_2016_558_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/025c/5225557/8ad2d25d6c9d/13023_2016_558_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/025c/5225557/a86530bcc2cc/13023_2016_558_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/025c/5225557/4e1712206a0f/13023_2016_558_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/025c/5225557/61c5fbff17e6/13023_2016_558_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/025c/5225557/803cf9570c86/13023_2016_558_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/025c/5225557/c88f8f6b2046/13023_2016_558_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/025c/5225557/1d73b18c5ea9/13023_2016_558_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/025c/5225557/8ad2d25d6c9d/13023_2016_558_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/025c/5225557/a86530bcc2cc/13023_2016_558_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/025c/5225557/4e1712206a0f/13023_2016_558_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/025c/5225557/61c5fbff17e6/13023_2016_558_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/025c/5225557/803cf9570c86/13023_2016_558_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/025c/5225557/c88f8f6b2046/13023_2016_558_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/025c/5225557/1d73b18c5ea9/13023_2016_558_Fig7_HTML.jpg

相似文献

1
Clinical, biochemical and molecular characteristics of Filipino patients with mucopolysaccharidosis type II - Hunter syndrome.菲律宾黏多糖贮积症II型——亨特综合征患者的临床、生化及分子特征
Orphanet J Rare Dis. 2017 Jan 11;12(1):7. doi: 10.1186/s13023-016-0558-0.
2
Molecular basis of iduronate-2-sulphatase gene mutations in patients with mucopolysaccharidosis type II (Hunter syndrome).II型粘多糖贮积症(亨特综合征)患者艾杜糖醛酸-2-硫酸酯酶基因突变的分子基础
J Med Genet. 1999 Jan;36(1):21-7.
3
The mutational spectrum of hunter syndrome reveals correlation between biochemical and clinical profiles in Tunisian patients.亨特综合征的突变谱揭示了突尼斯患者生化特征与临床特征之间的相关性。
BMC Med Genet. 2020 May 24;21(1):111. doi: 10.1186/s12881-020-01051-9.
4
Molecular analysis of 40 Italian patients with mucopolysaccharidosis type II: New mutations in the iduronate-2-sulfatase (IDS) gene.40例意大利II型黏多糖贮积症患者的分子分析:艾杜糖醛酸-2-硫酸酯酶(IDS)基因的新突变
Hum Mutat. 2001 Aug;18(2):164-5. doi: 10.1002/humu.1169.
5
A 38.8 kb deletion mutation of the iduronate-2-sulfatase gene in a patient with Hunter syndrome.一名亨特综合征患者中艾杜糖醛酸-2-硫酸酯酶基因的38.8 kb缺失突变
J Formos Med Assoc. 2005 Apr;104(4):273-5.
6
Prevention of Neurocognitive Deficiency in Mucopolysaccharidosis Type II Mice by Central Nervous System-Directed, AAV9-Mediated Iduronate Sulfatase Gene Transfer.通过中枢神经系统靶向、AAV9 介导的艾杜糖硫酸酯酶基因转移预防黏多糖贮积症 II 型小鼠的神经认知缺陷。
Hum Gene Ther. 2017 Aug;28(8):626-638. doi: 10.1089/hum.2016.184. Epub 2017 May 5.
7
Extension of the molecular analysis to the promoter region of the iduronate 2-sulfatase gene reveals genomic alterations in mucopolysaccharidosis type II patients with normal coding sequence.将分子分析扩展到艾杜糖-2-硫酸酯酶基因的启动子区域,揭示了编码序列正常的黏多糖贮积症 II 型患者的基因组改变。
Gene. 2013 Sep 10;526(2):150-4. doi: 10.1016/j.gene.2013.05.007. Epub 2013 May 21.
8
Mutations of the iduronate-2-sulfatase (IDS) gene in patients with Hunter syndrome (mucopolysaccharidosis II).亨特综合征(黏多糖贮积症II型)患者中艾杜糖醛酸-2-硫酸酯酶(IDS)基因的突变
Hum Mutat. 1994;4(2):128-31. doi: 10.1002/humu.1380040206.
9
Molecular diagnosis of 65 families with mucopolysaccharidosis type II (Hunter syndrome) characterized by 16 novel mutations in the IDS gene: Genetic, pathological, and structural studies on iduronate-2-sulfatase.对65个II型黏多糖贮积症(亨特综合征)家族的分子诊断:IDS基因中的16个新突变特征;艾杜糖醛酸-2-硫酸酯酶的遗传学、病理学及结构研究
Mol Genet Metab. 2016 Jul;118(3):190-197. doi: 10.1016/j.ymgme.2016.05.003. Epub 2016 May 7.
10
Endoplasmic Reticulum and Lysosomal Quality Control of Four Nonsense Mutants of Iduronate 2-Sulfatase Linked to Hunter's Syndrome.黏多糖贮积症Ⅱ型(Hunter 综合征)相关的艾杜糖-2-硫酸酯酶四个无义突变的内质网和溶酶体质量控制
DNA Cell Biol. 2020 Feb;39(2):226-234. doi: 10.1089/dna.2019.5221. Epub 2020 Jan 2.

引用本文的文献

1
Theological and Ethical Perspectives on Gene Editing and the Sanctity of Life: Rare Genetic Diseases in the Philippines as a Model.基因编辑与生命神圣性的神学和伦理视角:以菲律宾的罕见遗传病为例
J Relig Health. 2025 Apr 16. doi: 10.1007/s10943-025-02318-2.
2
Lysosomal Dysfunction: Connecting the Dots in the Landscape of Human Diseases.溶酶体功能障碍:梳理人类疾病图谱中的关联
Biology (Basel). 2024 Jan 7;13(1):34. doi: 10.3390/biology13010034.
3
Misdiagnosis in mucopolysaccharidoses.黏多糖贮积症的误诊。

本文引用的文献

1
Molecular diagnosis of 65 families with mucopolysaccharidosis type II (Hunter syndrome) characterized by 16 novel mutations in the IDS gene: Genetic, pathological, and structural studies on iduronate-2-sulfatase.对65个II型黏多糖贮积症(亨特综合征)家族的分子诊断:IDS基因中的16个新突变特征;艾杜糖醛酸-2-硫酸酯酶的遗传学、病理学及结构研究
Mol Genet Metab. 2016 Jul;118(3):190-197. doi: 10.1016/j.ymgme.2016.05.003. Epub 2016 May 7.
2
Deep Genotyping of the IDS Gene in Colombian Patients with Hunter Syndrome.哥伦比亚亨特综合征患者IDS基因的深度基因分型
JIMD Rep. 2015;19:101-9. doi: 10.1007/8904_2014_376. Epub 2015 Feb 15.
3
J Appl Genet. 2022 Sep;63(3):475-495. doi: 10.1007/s13353-022-00703-1. Epub 2022 May 13.
4
A review of the clinical outcomes in idursulfase-treated and untreated Filipino patients with mucopolysaccharidosis type II: data from the local lysosomal storage disease registry.对伊杜硫酸酶治疗和未治疗的菲律宾黏多糖贮积症 II 型患者的临床结局进行回顾:来自当地溶酶体贮积症登记处的数据。
Orphanet J Rare Dis. 2021 Jul 21;16(1):323. doi: 10.1186/s13023-021-01875-5.
5
Estimated prevalence of mucopolysaccharidoses from population-based exomes and genomes.基于外显子组和基因组的人群中黏多糖贮积症的估计患病率。
Orphanet J Rare Dis. 2020 Nov 18;15(1):324. doi: 10.1186/s13023-020-01608-0.
6
Natural history of cognitive development in neuronopathic mucopolysaccharidosis type II (Hunter syndrome): Contribution of genotype to cognitive developmental course.II型神经病变性黏多糖贮积症(亨特综合征)认知发展的自然史:基因型对认知发展进程的影响。
Mol Genet Metab Rep. 2020 Jul 29;24:100630. doi: 10.1016/j.ymgmr.2020.100630. eCollection 2020 Sep.
7
Hearing Loss in Mucopolysaccharidoses: Current Knowledge and Future Directions.黏多糖贮积症中的听力损失:当前认知与未来方向
Diagnostics (Basel). 2020 Aug 4;10(8):554. doi: 10.3390/diagnostics10080554.
8
The mutational spectrum of hunter syndrome reveals correlation between biochemical and clinical profiles in Tunisian patients.亨特综合征的突变谱揭示了突尼斯患者生化特征与临床特征之间的相关性。
BMC Med Genet. 2020 May 24;21(1):111. doi: 10.1186/s12881-020-01051-9.
9
ENT and mucopolysaccharidoses.耳鼻喉科学与黏多糖贮积症。
Ital J Pediatr. 2018 Nov 16;44(Suppl 2):127. doi: 10.1186/s13052-018-0555-0.
10
Early hematopoietic stem cell transplantation in a patient with severe mucopolysaccharidosis II: A 7 years follow-up.重度黏多糖贮积症II型患者的早期造血干细胞移植:7年随访
Mol Genet Metab Rep. 2017 Jun 8;12:62-68. doi: 10.1016/j.ymgmr.2017.05.010. eCollection 2017 Sep.
Airway-related symptoms and surgeries in patients with mucopolysaccharidosis I.
黏多糖贮积症 I 型患者的气道相关症状及手术
Ann Otol Rhinol Laryngol. 2015 Mar;124(3):198-205. doi: 10.1177/0003489414550154. Epub 2014 Sep 11.
4
Mucopolysaccharidosis type II: identification of 30 novel mutations among Latin American patients.黏多糖贮积症 II 型:在拉丁美洲患者中鉴定出 30 种新突变。
Mol Genet Metab. 2014 Feb;111(2):133-8. doi: 10.1016/j.ymgme.2013.08.011. Epub 2013 Sep 1.
5
A study of the relationship between clinical phenotypes and plasma iduronate-2-sulfatase enzyme activities in Hunter syndrome patients.亨特综合征患者临床表型与血浆艾杜糖醛酸-2-硫酸酯酶活性之间关系的研究。
Korean J Pediatr. 2012 Mar;55(3):88-92. doi: 10.3345/kjp.2012.55.3.88. Epub 2012 Mar 16.
6
Diagnosing Hunter syndrome in pediatric practice: practical considerations and common pitfalls.在儿科实践中诊断亨特综合征:实用注意事项和常见陷阱。
Eur J Pediatr. 2012 Apr;171(4):631-9. doi: 10.1007/s00431-012-1703-y. Epub 2012 Mar 1.
7
Analysis of the IDS gene in 38 patients with Hunter syndrome: the c.879G>A (p.Gln293Gln) synonymous variation in a female create exonic splicing.对 38 名亨特综合征患者的 IDS 基因进行分析:女性个体中的 c.879G>A(p.Gln293Gln)同义变异导致外显子剪接。
PLoS One. 2011;6(8):e22951. doi: 10.1371/journal.pone.0022951. Epub 2011 Aug 4.
8
Prevalence and characterization of cardiac involvement in Hunter syndrome.亨特综合征心脏受累的患病率及特征。
J Pediatr. 2011 Aug;159(2):327-31.e2. doi: 10.1016/j.jpeds.2011.01.054. Epub 2011 May 6.
9
Initial report from the Hunter Outcome Survey.猎人结果调查的初步报告。
Genet Med. 2008 Jul;10(7):508-16. doi: 10.1097/gim.0b013e31817701e6.
10
Molecular analysis of the iduronate-2-sulfatase gene in Thai patients with Hunter syndrome.对泰国亨特综合征患者的艾杜糖-2-硫酸酯酶基因进行分子分析。
J Inherit Metab Dis. 2008 Dec;31 Suppl 2:S303-11. doi: 10.1007/s10545-008-0876-z. Epub 2008 May 20.